Opella Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 11,000

Employees

  • Latest Deal Type
  • Debt Refin.

  • Financing Rounds
  • 5

Opella General Information

Description

Manufacturer of consumer healthcare products intended to simplify self-care and empower individual health management. The company's technology utilizes proprietary oral dosage forms and specialized science centers to produce allergy relief medicines, digestive wellness products, pain management treatments, cough and cold remedies, physical wellness supplements, and mental wellness aids, providing consumers with over-the-counter treatments for common health conditions and personal wellness management.

Contact Information

Website
www.opella.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 157 Avenue Charles de Gaulle
  • 92200 Neuilly sur Seine
  • France
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Personal Products
Corporate Office
  • 157 Avenue Charles de Gaulle
  • 92200 Neuilly sur Seine
  • France

Opella Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Opella Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Opella‘s full profile, request access.

Request a free trial

Opella Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of consumer healthcare products intended to simplify self-care and empower individual health management. Th
Pharmaceuticals
Neuilly sur Seine, France
11,000 As of 2026

Gentilly, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Opella Competitors (1)

One of Opella’s competitors is Sanofi, a Corporation company based in Gentilly, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sanofi Corporation Gentilly, France
You’re viewing 1 of 1 competitors. Get the full list »

Opella Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Opella Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Opella‘s full profile, request access.

Request a free trial

Opella FAQs

  • When was Opella founded?

    Opella was founded in 2018.

  • Where is Opella headquartered?

    Opella is headquartered in Neuilly sur Seine, France.

  • What is the size of Opella?

    Opella has 11,000 total employees.

  • What industry is Opella in?

    Opella’s primary industry is Pharmaceuticals.

  • Is Opella a private or public company?

    Opella is a Private company.

  • What is Opella’s current revenue?

    The current revenue for Opella is .

  • How much funding has Opella raised over time?

    Opella has raised $9.7B.

  • Who are Opella’s investors?

    Bpifrance, Clayton, Dubilier & Rice, Sanofi, Alberta Investment Management, and Lunate are 5 of 6 investors who have invested in Opella.

  • Who are Opella’s competitors?

    Sanofi is a competitor of Opella.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process